Animal Health
Elanco Announces Global Agreement with Ab E Discovery for New Technology
Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), is pleased to announce a new global in-licensing agreement with Ab E Discovery to further develop and bring to market an egg antibody […]